CROI 2016 Program at a Glance

Keyword Index

Transmitted HIV drug resistance - 478, 481, 482 Transplantation - 264, 356 Transport - 180 Treatment - 146, 156, 605, 999 • As prevention – 169LB, 167, 535, 989, 1054, 1063 • Cascade – 172, 1048 • Experienced - 472 • Initiation - 112, 1048 • Interruption - 332 • Naïve adults - 470, 509 • Outcomes - 755

Vaginal film - 871 Vaginal gel - 875 Vaginal mucosa - 288 Vaginal ring - 872, 873, 877, 1057, 1058 Validation study - 907 Vascular disease - 41 Vertical transmission - 839 Veterans - 714 Vif - 59, 199, 200, 202 Viral • Decay - 751, 947 • Diversity - 33, 215, 218 • Fitness - 197 • Hepatitis - 64, 545, 594, 609 • Kinetics – 357, 956 • Load - 304, 952, 993, 1024, 1027, 1029 • Load monitoring - 795, 832 • Outgrowth - 361 • Persistence – 73LB, 333 • Rebound – 32LB, 346, 831, 832 • Replication - 151, 195, 378, 465, 592, 828 • reservoir - 229, 333, 336, 356, 361, 372, 837 • reservoir - 311LB • RNA agonist - 371 • sequences - 331, 339 • suppression - 27, 53, 111, 116, 832, 1002, 1027, 1028, 1035, 1037 Viremia - 795 Virologic Visceral adipose tissue - 704 Vitamin D - 700, 798, 826, 859 VMMC - 165 Vorinostat - 355 Vpr - 185 Vulnerable populations - 79 –W– Waist circumference - 704 Weight gain - 858 West Africa - 434, 568, 923, 961, 962, 1015, 1047 West Africa - 75LB Western Blot - 515 White matter abnormalities - 148 World Health Organization (WHO) - 477 World Health Organization (WHO) guidelines - 666, 1011, 1020, 1048 • Control - 39, 209LB, 347 • Failure - 484, 956, 1039 • Monitoring - 502 • Outcomes - 346, 502 • Response - 796 • Suppression - 391, 953, 1040

Women – 109LB, 162, 277, 593, 647, 650, 706, 720, 793, 794, 861, 1047, 1058 –X– Xpert MTB/RIF – 742, 750 –Y– Y chromosomal DNA - 865 Yellow fever vaccine - 326 Young adults - 177, 826, 830, 856, 859, 900 Young black MSM - 217, 832, 930, 993 –Z– Zidovudine - 205, 962 Zinc finger nucleases – 356, 358LB Zoledronic acid - 47

TREG - 258LB Trends - 895 TRIM22 - 246 TRIM5alpha - 206

TRIMCyp - 206 Tropism - 509 Truvada - 885, 888, 892, 894 Tuberculosis – 115, 156, 743, 769

• And HIV - 14, 157, 398, 457, 734, 738, 741LB, 744, 746, 747, 751, 753, 755, 756, 758, 1053 • Diagnosis - 742, 746, 747, 749, 758 • Drug resistance - 14 • Incidence – 752 • In pregnancy - 757, 758 • Prophylaxis - 747 • Surveillance - 1053 Type 1 interferon - 135, 322, 781 TZA-Assay - 341 –U– Uganda – 444, 594 Ultradeep sequencing - 489, 509, 827, 950 Ultrasensitive viral load - 839 UNAIDS 90-90-90 - 111 United States - 216, 593, 772, 830, 935, 1006, 1051

Universal ART coverage - 114, 117 Unprotected intercourse - 286, 912 Uptake - 883LB Urine biomarkers - 763 Urine LAM testing - 747 Urine lipoarabinomannan - 748 USA - 883LB, 917 Usage - 883LB –V– Vaccination - 161 Vaccine – 76LB, 319, 321, 591 Vaccine response - 325, 328, 825 VACS - 645

Keyword Index

CROI 2016 175